Literature DB >> 26345093

Screening for genetic mutations in LDLR gene with familial hypercholesterolemia patients in the Saudi population.

Khalid Khalaf Alharbi1, Tarek S Kashour2, Wejdan Al-Hussaini3, May Salem Nbaheen4, Rana M W Hasanato5, Sarar Mohamed6, Waleed Tamimi7, Imran Ali Khan1.   

Abstract

Familial hypercholesterolemia (FH) is caused by genetic defects involving the low density lipoprotein-receptor (LDL-R), predisposing affected people to premature atherosclerotic cardiovascular disease and death. The aim of the present study was to assess certain exons in the LDLR gene mutation detection analysis affecting in the Saudi population with FH. This case-control study was carried out with 200 subjects; 100 were FH cases and 100 were healthy controls. Five mL of venous blood samples were collected from all the subjects and used for biochemical and genetic analysis. DNA was extracted from 2 mL of the EDTA samples, and precise primers were designed for LDL-R gene which includes Exon 3, 4 and 8. PCR was followed by DNA sequencing. In our study, we found 25 mutations in cases in Exon-3 and 2 mutations in controls, however, we have found only 5 mutations in exon 4 and none of the mutations were identified in exon 8. We conclude that screening of FH among Saudi population is very important to identify individuals who are prone to develop the disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26345093     DOI: 10.18388/abp.2015_1015

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  9 in total

Review 1.  The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry.

Authors:  Faisal Alallaf; Fatima Amanullah H Nazar; Majed Alnefaie; Adel Almaymuni; Omran Mohammed Rashidi; Khalid Alhabib; Fahad Alnouri; Mohamed-Nabil Alama; Mohammad Athar; Zuhier Awan
Journal:  Open Cardiovasc Med J       Date:  2017-07-26

2.  US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.

Authors:  Zahid S Ahmad; Rolf L Andersen; Lars H Andersen; Emily C O'Brien; Iris Kindt; Peter Shrader; Chandna Vasandani; Connie B Newman; Emil M deGoma; Seth J Baum; Linda C Hemphill; Lisa C Hudgins; Catherine D Ahmed; Iftikhar J Kullo; Samuel S Gidding; Danielle Duffy; William Neal; Katherine Wilemon; Matthew T Roe; Daniel J Rader; Christie M Ballantyne; MacRae F Linton; P Barton Duell; Michael D Shapiro; Patrick M Moriarty; Joshua W Knowles
Journal:  J Clin Lipidol       Date:  2016-08-06       Impact factor: 4.766

3.  Association between HindIII (rs320) variant in the lipoprotein lipase gene and the presence of coronary artery disease and stroke among the Saudi population.

Authors:  Neda M Bogari; Ashwag Aljohani; Anas Dannoun; Osama Elkhateeb; Masimo Porqueddu; Amr A Amin; Dema N Bogari; Mohiuddin M Taher; Faruk Buba; Reem M Allam; Mustafa N Bogari; Francesco Alamanni
Journal:  Saudi J Biol Sci       Date:  2020-06-24       Impact factor: 4.219

4.  Q192R polymorphism in the PON1 gene and familial hypercholesterolemia in a Saudi population.

Authors:  Khalid Khalaf Alharbi; May Salem Alnbaheen; Fawiziah Khalaf Alharbi; Rana M Hasanato; Imran Ali Khan
Journal:  Ann Saudi Med       Date:  2017 Nov-Dec       Impact factor: 1.526

5.  Characterization and antifungal activity of the yellow pigment produced by a Bacillus sp. DBS4 isolated from the lichen Dirinaria agealita.

Authors:  Turki M Dawoud; Naiyf S Alharbi; Aswani M Theruvinthalakal; Aswani Thekkangil; Shine Kadaikunnan; Jamal M Khaled; Taghreed N Almanaa; Karthikumar Sankar; Ganesh Moorthy Innasimuthu; Khaled F Alanzi; Shyam Kumar Rajaram
Journal:  Saudi J Biol Sci       Date:  2019-11-29       Impact factor: 4.219

Review 6.  Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World Setting.

Authors:  Moeber Mahzari; Hawazen Zarif
Journal:  Adv Ther       Date:  2021-04-07       Impact factor: 3.845

7.  Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.

Authors:  Joana Rita Chora; Ana Margarida Medeiros; Ana Catarina Alves; Mafalda Bourbon
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.822

8.  Xanthomas Can Be Misdiagnosed and Mistreated in Homozygous Familial Hypercholesterolemia Patients: A Call for Increased Awareness Among Dermatologists and Health Care Practitioners.

Authors:  Fahad Alnouri; Faisal A Al-Allaf; Mohammad Athar; Zainularifeen Abduljaleel; Moheeb Alabdullah; Dalal Alammari; Menwar Alanazi; Fahmi Alkaf; Abeer Allehyani; Mohammad A Alotaiby; Abdullah Alshehri; Abdellatif Bouazzaoui; Hussam Karrar; Mohiuddin M Taher
Journal:  Glob Heart       Date:  2020-02-28

9.  Screening of common genetic variants in the APOB gene related to familial hypercholesterolemia in a Saudi population: A case-control study.

Authors:  Mohammed Ali Batais; Turky H Almigbal; Noor Ahmad Shaik; Fawaziah Khalaf Alharbi; Khalid Khalaf Alharbi; Imran Ali Khan
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.